Naturaline Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 30.08%
(FY 2022)
- Profit -276.46%
(FY 2022)
- Ebitda 13.05%
(FY 2022)
- Net Worth -46.99%
(FY 2022)
- Total Assets -2.00%
(FY 2022)
About Naturaline Nutraceuticals
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suraj Vasanth and Sureka Vasanth serve as directors at the Company.
- CIN/LLPIN
U52609KA2017PTC101444
- Company No.
101444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Naturaline Nutraceuticals Private Limited offer?
Naturaline Nutraceuticals Private Limited offers a wide range of products and services, including Flavours & Aromatics, Artificial Sweetener, Common Disease Medicines, Nasal Drops, Plastic Containers & Bottles, Pharmaceutical Containers, Child and Baby Care Products, Baby Nipples, Hand Sanitizers & Personal Hygiene, Toiletry Set.
Who are the key members and board of directors at Naturaline Nutraceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suraj Vasanth  | Managing Director | 17-Mar-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sureka Vasanth | Director | 12-Sep-2018 | Current |
Financial Performance of Naturaline Nutraceuticals.
Naturaline Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.08% increase. The company also saw a substantial fall in profitability, with a 276.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Naturaline Nutraceuticals?
Unlock access to Naturaline Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Naturaline Nutraceuticals?
Unlock and access historical data on people associated with Naturaline Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naturaline Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naturaline Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
